SCHEMBL487360

SCHEMBL487360

CC(=O)c1ccc(S)cc1

nearest known ligand 0.54

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
MAPT P10636 5/20 0.54
HPGD P15428 4/20 0.54
RAB9A P51151 4/20 0.54
LMNA P02545 2/20 0.54
L3MBTL1 Q9Y468 2/20 0.54
KMT2A Q03164 2/20 0.54
SMN1; SMN2 Q16637 3/20 0.52
HSD17B1 P14061 1/20 0.52
MAPK1 P28482 2/20 0.48
NOS3 P29474 2/20 0.48
NOS1 P29475 2/20 0.48
NPC1 O15118 3/20 0.46
ALDH1A1 P00352 1/20 0.46
STAT3 P40763 1/20 0.46
STAT1 P42224 1/20 0.46
TDP1 Q9NUW8 1/20 0.46
GAA P10253 1/20 0.45
TAAR1 Q96RJ0 1/20 0.43
STS P08842 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6511474 0.97 MAPT (0.52) MAPTHPGDRAB9ALMNAL3MBTL1
Methane SCHEMBL8806303 0.97 MAPT (0.52) MAPTHPGDRAB9ALMNAL3MBTL1
SCHEMBL6517451 0.97 MAPT (0.52) MAPTHPGDRAB9ALMNAL3MBTL1
Benzene SCHEMBL28493451 0.95 MAPT (0.60) MAPTHPGDRAB9ALMNAL3MBTL1
Acetic Acid SCHEMBL9711112 0.95 MAPT (0.54) MAPTHPGDRAB9ALMNAL3MBTL1
SCHEMBL11162701 0.93 HSD17B1 (0.64) MAPTHPGDRAB9ALMNAL3MBTL1
Cyanate SCHEMBL27874992 0.89 MAPT (0.45) MAPTHPGDRAB9ALMNAL3MBTL1
SCHEMBL12141690 0.87 HPGD (0.79) MAPTHPGDRAB9ALMNAL3MBTL1
SCHEMBL12141679 0.87 HPGD (0.79) MAPTHPGDRAB9ALMNAL3MBTL1
SCHEMBL50646 0.85 MAPT (0.68) MAPTHPGDRAB9ALMNAL3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 503 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4581071-A1 METHOD FOR PRODUCING A MATERIAL FOR A MEMBRANE, MATERIAL, MEMBRANE AND USE OF A MEMBRANE Forschungszentrum Jülich GmbH (DE) 2025-07-09 EP claimed
CN-119707759-A Preparation method of 4-mercaptoacetophenone 大连双硼医药化工有限公司 2025-03-28 CN claimed
WO-2024046712-A1 METHOD FOR PRODUCING A MATERIAL FOR A MEMBRANE, MATERIAL, MEMBRANE AND USE OF A MEMBRANE Forschungszentrum Jülich GmbH (DE) 2024-03-07 WO claimed
WO-2023190693-A1 RESIN COMPOSITION FOR OPTICAL WAVEGUIDE, DRY FILM FOR OPTICAL WAVEGUIDE, AND OPTICAL WAVEGUIDE パナソニックIPマネジメント株式会社 2023-10-05 WO claimed
CN-106726623-B Single-component photocuring composite material with fluoride ion release characteristic for dental restoration and application thereof 日照沪鸽生物材料有限公司 2020-12-04 CN claimed
EP-1598349-B1 NOVEL 2-PYRIDINECARBOXAMIDE DERIVATIVES MSD KK (JP) 2011-07-27 EP claimed
EP-1268561-B1 METHOD FOR PRODUCING POLYMERS BASF SE (DE) 2009-01-28 EP claimed
US-6809165-B2 Method for producing polymers BASF AKTIENGESELLSCHAFT (DE) 2004-10-26 US claimed
US-20030125329-A1 Substituted polycyclic aryl and heteroaryl tertiary-heteroalkylamines useful for inhibiting cholesteryl ester transfer protein activity G.D. SEARLE & CO. 2003-07-03 US claimed
US-20030125328-A1 Substituted polycyclic aryl and heteroaryl tertiary-heteroalkylamines useful for inhibiting cholesteryl ester transfer protein activity G.D. SEARLE & CO. (US) 2003-07-03 US claimed
EP-1268561-A2 METHOD FOR PRODUCING POLYMERS BASF AKTIENGESELLSCHAFT (DE) 2003-01-02 EP claimed
US-20020165232-A1 Substituted N, N-disubstituted cycloalkyl aminoalcohol compounds useful for inhibiting cholesteryl ester transfer protein activity SIKORSKI JAMES A (US) 2002-11-07 US claimed
US-20020165231-A1 Substituted N-heteroaryl-N-phenyl aminoalcohol compounds useful for inhibiting cholesteryl ester transfer protein activity SIKORSKI JAMES A (US) 2002-11-07 US claimed
WO-2001074908-A2 METHOD FOR PRODUCING POLYMERS BASF AKTIENGESELLSCHAFT (DE) 2001-10-11 WO claimed
EP-1115693-A1 SUBSTITUTED POLYCYCLIC ARYL AND HETEROARYL $i(TERTIARY)-HETEROALKYLAMINES USEFUL FOR INHIBITING CHOLESTERYL ESTER TRANSFER PROTEIN ACTIVITY Monsanto Company (US) 2001-07-18 EP claimed
WO-2000018721-A1 SUBSTITUTED POLYCYCLIC ARYL AND HETEROARYL TERTIARY-HETEROALKYLAMINES USEFUL FOR INHIBITING CHOLESTERYL ESTER TRANSFER PROTEIN ACTIVITY MONSANTO COMPANY (US) 2000-04-06 WO claimed
EP-0271307-B1 METHOD FOR PRODUCING ALKENYLTHIOPHENOLS AND THEIR ESTERS HOECHST CELANESE CORPORATION (US) 1992-01-02 EP claimed
EP-0302321-A2 Process for the preparation of thiophenols, and these thiophenols BAYER AG (DE) 1989-02-08 EP claimed
US-4794205-A Method for producing alkenylthiophenols and their esters HOECHST CELANESE CORPORATION (US) 1988-12-27 US claimed
EP-0271307-A2 Method for producing alkenylthiophenols and their esters HOECHST CELANESE CORPORATION (US) 1988-06-15 EP claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030125328-A1 Substituted polycyclic aryl and heteroaryl tertiary-heteroalkylamines useful for inhibiting cholesteryl ester transfer protein activity CETP, MTTP, LCAT MAPT 3088/4885HPGD 3701/4885RAB9A 3063/4885
US-20020165231-A1 Substituted N-heteroaryl-N-phenyl aminoalcohol compounds useful for inhibiting cholesteryl ester transfer protein activity CETP, LCAT, MTTP MAPT 2318/4885HPGD 2926/4885RAB9A 3242/4885
US-20020165232-A1 Substituted N, N-disubstituted cycloalkyl aminoalcohol compounds useful for inhibiting cholesteryl ester transfer protein activity CETP, DBI, PLTP MAPT 3071/4885HPGD 2907/4885RAB9A 3601/4885
US-20030125329-A1 Substituted polycyclic aryl and heteroaryl tertiary-heteroalkylamines useful for inhibiting cholesteryl ester transfer protein activity CETP, MTTP, LCAT MAPT 3088/4885HPGD 3701/4885RAB9A 3063/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.